Definitions Flashcards

1
Q

Permission to examine, analyze, verify, & reproduce any records and reports important to a trial

A

direct access

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

comparator

A

product or placebo used in an investigation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LAR

A

legally authorized representative (for a patient)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a short form

A

document that states the elements of the informed consent have been presented orally to and understood by participant or LAR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

short form consent, oral presentation, and summary are examples of what?

A

components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

when are components used?

A

-when a non-English translated IC is not available
-when window of treatment is short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Data & safety monitoring plan

A

a plan that is used to ensure the safety of subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A group of experts that review research data to ensure subject safety & data validity

A

Data safety monitoring committee

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is blinding?

A

Method where personnel involved in a trial are intentionally prevented from knowing the treatment arms/treatment assignment to patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which blinding type: sponsor, PI/staff & patients are blinded

A

triple blind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How many types of blinding are there?

A

4 types
- triple
-double
-single
-open label (none)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

single blinding

A

when only the subjects are blinded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

double blinding

A

PI/staff & subjects are blinded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NIDPOE

A

Notice of initiation of disqualification proceedings & opportunity to explain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When is a NIDPOE issued by the FDA?

A

When an investigator may be disqualified due to non-compliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

randomization

A

method where subjects are randomly assigned into different treatment arms.

17
Q

cirriculum vitae

A

Qualifications of the investigator showing education, training, & experience that qualifies them as an expert

18
Q

CAPA

A

Corrective & preventative actions

19
Q

What is CAPA

A

Process to identify root cause of issues or problems & actions to resolve them

20
Q

ICH

A

International Council for Harmonization

21
Q

HHS

A

Department of Health and Human Services

22
Q

The World Medical Association is involved with which foundation?

A

The Declaration of Helsinki

23
Q

3 principles of the Belmont Report

A
  1. Respect of persons
  2. Beneficence
  3. Justice
24
Q

The 2 expressions of beneficent actions in terms of human trials/ethical principles

A
  1. Do not harm
  2. Maximize possible benefits and minimize possible harms
25
Q

Biochemical & physiological effects of a drug

A

Pharmacodynamic

26
Q

Activity of a drug in the body over time

A

Pharmacokinetic

27
Q

Stratification is ___ and an example is ___

A

Arrangement of classification of something into different groups.
Randomizing men and women separately because a drug may metabolize differently for each gender

28
Q

Significant risk device

A

Investigational device that presents a potential for serious risk to the health, safety, or welfare of a subject

29
Q

A device that does not meet the definition of a significant risk device

A

Non-significant risk device

30
Q

Measures believed to quantify the potential effect of a treatment or therapy

A

Endpoints

31
Q

Audit’s major purpose

A

To confirm site is confirming SOPs are being upheld

32
Q

To oversee sponsor, monitor, investigator & IRB to determine whether all groups meet regulatory responsibilities

A

Inspection

33
Q

To ensure that study & procedures are properly documented & verify the integrity of data

A

To audit

34
Q

What is indemnification?

A

The definition of duties and responsibilities of the involved parties in cases of loss or injury linked to a clinical trial